HC Wainwright Has Bullish Forecast for PLX Q1 Earnings
Protalix BioTherapeutics, Inc. (NYSE:PLX – Free Report) – Equities research analysts at HC Wainwright raised their Q1 2025 earnings per share (EPS) estimates for Protalix BioTherapeutics in a research note issued to investors on Monday, April 28th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of $0.08 per share for […]
Protalix BioTherapeutics, Inc. (NYSE:PLX – Free Report) – Equities research analysts at HC Wainwright raised their Q1 2025 earnings per share (EPS) estimates for Protalix BioTherapeutics in a research note issued to investors on Monday, April 28th. HC Wainwright analyst R. Selvaraju now anticipates that the company will post earnings of $0.08 per share for […]
